share_log

Aphex BioCleanse Systems, Inc (OTC:SNST) Suspends Director Scott Smith

Aphex BioCleanse Systems, Inc (OTC:SNST) Suspends Director Scott Smith

Aphex生物清洁系统公司(场外交易代码:SNST)暂停董事交易斯科特·史密斯
GlobeNewswire ·  2022/02/19 01:50

PITTSFORD, NY, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTC Pink: SNST), a forward-thinking, publicly traded company, announces it has come to the attention of the Board of Directors of Aphex BioCleanse Systems, Inc., that on February 10, 2022, Board Member Scott Smith filed a legal action in the U.S. District Court for Massachusetts against the Company and two of its Directors.

环球通讯社纽约州匹兹福德2022年2月18日电Aphex BioCleanse Systems,Inc.(场外交易代码:SNST)是一家具有前瞻性的上市公司,该公司宣布已经引起Aphex BioCleanse Systems,Inc.董事会的注意,董事会成员斯科特·史密斯于2022年2月10日向美国马萨诸塞州地区法院提起诉讼,起诉该公司及其两名董事。

The object of the lawsuit is not to benefit the Company's shareholders but to financially benefit Scott Smith individually, and the litigation potentially damages shareholder interests. This litigation also clearly violates the "Schoon Doctrine", (Schoon v. Smith, No. 554, 2006 Del. Feb. 12, 2008)

诉讼的目的不是让公司的股东受益,而是让斯科特·史密斯个人在财务上受益,诉讼可能会损害股东的利益。这起诉讼也明显违反了“肖恩原则”(Schoon诉Smith,No.554,2006年5月)。2008年2月12日)

The Schoon Doctrine supports that acting Directors cannot bring actions against the Company, its Directors and/or Officers that are not in the interests of the Company and as such breaches the fiduciary responsibility of each the Director to the shareholders.

肖恩主义支持代理董事不得对本公司、其董事和/或高级管理人员提起不符合本公司利益的诉讼,因此违反了董事各自对股东的受信责任。

Accordingly, the Chairman of the Aphex Board of Directors, Thomas Fitzgerald has determined, effective immediately, to suspend Scott Smith from any, and all duties as a Board Director, pending a complete investigation of this matter and allow a review by the other full Board members.

因此,Aphex董事会主席托马斯·菲茨杰拉德决定,在对此事进行全面调查并允许其他董事会成员进行审查之前,立即暂停斯科特·史密斯作为董事公司董事会成员的所有职务。

Investor Contact:
Jon Olson, CEO
Milestone Management Services
Jon@milestonemanagementservicesllc.com
702-217-9518

投资者联系方式:
乔恩·奥尔森(Jon Olson),首席执行官
里程碑管理服务
邮箱:jon@milestonemanagementservicesllc.com
702-217-9518

About Aphex BioCleanse Systems, Inc.
Aphex BioCleanse Systems, Inc. is the developer of the world's first proprietary non-alcohol, non-toxic, hydrogen-based cleaning technology, and has been producing germ killing solutions for over 10 years. The technology, called Hy-IQ® Water, has a unique method of sanitizing that uses hydrogen ions traveling nearly at the speed of light to breach the cell walls of exoskeleton germs. "We Kill Germs with Physics, Not Chemistry" is a tagline that expresses their commitment to the environment by providing non-Chemical solutions to the spread of dangerous pathogens.  Killing the most dangerous germs on the planet, while meeting the EPA's definition of "Water" is revolutionary. With world leading teams and technology, Aphex is doing its part to make the world a safer place. To find out more about Aphex and their technologies, visit: Aphex BioCleanse Systems, Inc. - Superior Sanitization (aphexus.com).

Aphex BioCleanse系统公司简介
Aphex BioCleanse Systems,Inc.是世界上第一个无酒精、无毒、基于氢气的专有清洁技术的开发商,生产杀菌解决方案已有10多年的历史。这项名为Hy-IQ®Water的技术有一种独特的消毒方法,它使用氢离子以接近光速的速度移动,以突破外骨骼细菌的细胞壁。“我们用物理而不是化学杀死细菌”是一句标语,通过为危险病原体的传播提供非化学解决方案来表达他们对环境的承诺。杀灭地球上最危险的细菌,同时满足环境保护局对“水”的定义是革命性的。凭借世界领先的团队和技术,Aphex正在为让世界变得更安全而尽自己的一份力量。欲了解更多有关Aphex及其技术的信息,请访问:Aphex BioCleanse Systems,Inc.-Superior Sanitiization(apexus.com)。

Forward Looking Statements
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future, including but not limited to, any products sold or cash flow from operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

前瞻性陈述
本新闻稿包含“前瞻性陈述”,这一术语在1933年“美国证券法”第27A节和1934年“证券交易法”第21E节中有定义。本新闻稿中非纯粹历史性的陈述均为前瞻性陈述,包括有关对未来的信念、计划、预期或意图的任何陈述,包括但不限于已售出的任何产品或来自运营的现金流。由于许多因素,实际结果可能与任何前瞻性陈述中预测的结果不同。这些因素除其他外,包括与分销有关的固有不确定性,以及与以可接受的条件获得融资有关的困难。这些前瞻性陈述是截至本新闻稿发布之日作出的,我们没有义务更新前瞻性陈述,也没有义务更新实际结果可能与前瞻性陈述中预测的结果不同的原因。尽管我们相信本新闻稿中包含的信念、计划、预期和意图是合理的,但不能保证这些信念、计划、预期或意图将被证明是准确的。投资者应参考本文提供的所有信息,还应参考我们上一财年的最新年度报告、季度报告以及不定期向美国证券交易委员会提交的其他定期报告。


译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发